Friday, ImmunityBio said the two complete responses are ongoing after seven and 15 months. The patients received four cycles ...

The patient with significant bone marrow involvement had complete bone morphological remission. In this patient in which 95% ...

Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, ...

CAR T cells have made headlines for their ability to fight hematological cancers, but they have proven largely ineffective ...

Natural killer cells, or NK cells, are elements of the immune system capable of rapidly locating and destroying cancerous or ...

Chimeric antigen receptor natural killer (CAR-NK) cell therapy is emerging as a promising next-generation immunotherapy with ...

Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...

Researchers developed the first genome-wide CRISPR screening tool for primary human natural killer (NK) cells Study revealed critical regulators of NK cell activity that can be targeted to improve ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, ...